New Horizon Health Ltd
HKEX:6606
New Horizon Health Ltd
HKEX:6606
Price:
14.14 HKD
Market Closed
Updated:
May 7, 2024
Section:
Relative Value
The Relative Value of one
New Horizon Health Ltd
stock under the Base Case scenario is
33.95
HKD.
Compared to the current market price of 14.14 HKD,
New Horizon Health Ltd
is
Undervalued by 58%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
33.95
HKD
Undervaluation 58%
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
New Horizon Health Ltd Competitors
New Horizon Health Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
New Horizon Health Ltd
HKEX:6606
|
6.5B HKD | 4.4 | 53.9 | -43.2 | -43.2 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
90.8B EUR | 0.5 | 27 | 9.7 | 12.9 | |
| US |
|
Cigna Corp
NYSE:CI
|
97.3B USD | 0.5 | 26.9 | 9.7 | 12.9 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
70.1B USD | 0.2 | 9.6 | 8.7 | 8.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
16.9B USD | 1.4 | 39.1 | 11.9 | 17.9 | |
| DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.6B EUR | 0.7 | -26.3 | 10 | 22.5 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.1B USD | 1.6 | 17.9 | 10.7 | 14.5 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.9B EUR | 0.6 | 21.7 | 6.7 | 15.8 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
11.5B EUR | 0.6 | 23 | 6.9 | 16.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12B USD | 1 | 14.7 | 8.3 | 11.9 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
